STANDIGM
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Standigm named as a Tech Innovator in Generative AI in Drug Discovery use case 2023-12-19 22:00
Standigm's "Green Ribbon Campaign" to support Mitochondria Disease Awareness Week 2023-09-12 21:00
Standigm and Nashville Biosciences join to revolutionize early drug discovery 2023-08-10 21:07
Standigm announces Younsung Choo as chief executive officer 2023-04-13 00:07
Standigm and Institut Pasteur Korea Identify Lead Compounds for Resistant Tuberculosis Thanks to Right Foundation Grant 2023-04-05 00:07
Standigm cited as 'Top 10 Generative AI-based startup based on VC Investment, 2019-2021' in Gartner® report 2023-01-05 22:00
Standigm Synthetic Research Center successfully accelerates drug discovery in its first year 2022-11-17 08:45
STANDIGM TO ATTEND BIO-EUROPE® 2022 2022-10-19 01:50
Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery 2022-08-18 20:30
STANDIGM WINS GOLD AND BRONZE STEVIE® AWARDS IN 2022 INTERNATIONAL BUSINESS AWARDS® 2022-08-16 20:30
Standigm Signs MOU with Merck Korea for AI drug Discovery Research 2022-06-09 14:46
Standigm Signs MOU with Merck Korea for AI drug Discovery Research 2022-06-01 21:00
Standigm signs MOU with Institut Pasteur Korea for AI-based drug discovery research on infectious disease 2021-11-30 21:30
Standigm Established a Synthetic Research Center to Improve Efficiency of AI Drug Discovery 2021-11-09 10:47
Standigm Files PCT Patent Application of AI-driven Repurposed Drugs for Primary Mitochondrial Disease 2021-11-03 21:00
1